State of the Digital Medicine Industry

January 19, 2017 Christoph Graener

Tools that will usher in a new age of healthcare are changing the game by creating more effective R&D processes, strengthening the patient-physician relationship, and simultaneously enabling individuals to become the CEO of their own health. This panel examines how these industry leaders are defining the meaning of digital medicine, the therapeutic applications, industry trends and forecasts for 2017.

Moderator: Nicole Fisher – HHR Strategies

  • Adam Brickman – Omada Health
  • Glen de Vries – Medidata
  • Naomi Fried – Health Innovation Strategies
  • Walter Greenleaf – Pear Therapeutics; Virtual Human Interaction Lab, Stanford University

Previous Article
What’s ahead with the new Trump administration?

The life sciences industry has had some challenging moments with lawmakers in recent years. So, how will th...

Next Article
The real-world evidence revolution: Finding value and relevance through the stakeholder perspective

The session discusses how the biopharma industry is adjusting its approach to R&D to deliver more meaningfu...